DSM : Preview 1Q21 trading update due 5 May
>We forecast adjusted EBITDA of € 427m, 1% above consensus - DSM will report its 1Q21 trading update on 5 May at 07.00 CET. There is no conference call. We forecast adjusted EBITDA of € 427m, up 9% yoy and 1% above consensus (Vara).We are in line on Nutrition and above consensus on Materials - We expect 1Q21 sales of € 2,170m, up 6% yoy (volumes 6%, prices 0%) and 1% ahead of consensus. We forecast Nutrition adjusted EBITDA of € 351m, up 8% yoy and in...Royal DSM is engaged in the creation of products and services in Life Sciences and Materials Sciences. Co.'s products and services are used globally in range of markets and applications in healthcare, pharmaceutical automotive and chemicals sectors. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. The activities of Co. are grouped into four clusters: Nutrition, Pharma, Performance Materials and Polymer Intermediates.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.